Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Pediatric Nephrology (Berlin, Germany)
|
July 28, 2005
Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism
S Faisal Ahmed, Shiuli Russell, Rajeeb Rashid, et al.
Nuclear Medicine Communications
|
May 7, 2020
Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence
Laura May Davis, N Nicou, Wendy Martin, et al.
Protein Expression and Purification
|
May 25, 1999
High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials
A E Frankel, J Ramage, A Latimer, et al.
Journal of Hepatology
|
February 7, 1998
The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients
M McCarthy, J Ramage, A McNair, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 6, 2006
Body composition and nutritional intake in children with chronic kidney disease
Rajeeb Rashid, Esther Neill, Wilma Smith, et al.
Alimentary Pharmacology & Therapeutics
|
September 21, 2006
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study
G D'Haens, D Hommes, L Engels, et al.
Leukemia
|
May 23, 2001
Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice
M Kiser, J A McCubrey, L S Steelman, et al.
Toxicology and Applied Pharmacology
|
July 17, 1999
Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeys
C E Hotchkiss, P D Hall, J M Cline, et al.
Leukemia
|
April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
A E Frankel, J A McCubrey, M S Miller, et al.
Molecules (Basel, Switzerland)
|
October 20, 2018
Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease
James Doonan, David Thomas, Michelle H Wong, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Pediatric Nephrology (Berlin, Germany)
|
July 28, 2005
Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism
S Faisal Ahmed, Shiuli Russell, Rajeeb Rashid, et al.
Nuclear Medicine Communications
|
May 7, 2020
Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence
Laura May Davis, N Nicou, Wendy Martin, et al.
Protein Expression and Purification
|
May 25, 1999
High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials
A E Frankel, J Ramage, A Latimer, et al.
Journal of Hepatology
|
February 7, 1998
The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients
M McCarthy, J Ramage, A McNair, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 6, 2006
Body composition and nutritional intake in children with chronic kidney disease
Rajeeb Rashid, Esther Neill, Wilma Smith, et al.
Alimentary Pharmacology & Therapeutics
|
September 21, 2006
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study
G D'Haens, D Hommes, L Engels, et al.
Leukemia
|
May 23, 2001
Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice
M Kiser, J A McCubrey, L S Steelman, et al.
Toxicology and Applied Pharmacology
|
July 17, 1999
Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeys
C E Hotchkiss, P D Hall, J M Cline, et al.
Leukemia
|
April 14, 2000
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias
A E Frankel, J A McCubrey, M S Miller, et al.
Molecules (Basel, Switzerland)
|
October 20, 2018
Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease
James Doonan, David Thomas, Michelle H Wong, et al.
Page
of 6